These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 33008316

  • 1. The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods.
    Duri K, Gumbo FZ, Munjoma PT, Chandiwana P, Mhandire K, Ziruma A, Macpherson A, Rusakaniko S, Gomo E, Misselwitz B, Mazengera LR, UZ-CHS Birth Cohort Team.
    BMC Infect Dis; 2020 Oct 02; 20(1):725. PubMed ID: 33008316
    [Abstract] [Full Text] [Related]

  • 2. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM, Abrams EJ, Donald KA, Brittain K, Phillips TK, Zerbe A, le Roux DM, Kroon M, Myer L.
    Lancet Child Adolesc Health; 2020 Mar 02; 4(3):220-231. PubMed ID: 31932246
    [Abstract] [Full Text] [Related]

  • 3. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM, Abrams EJ, Donald KA, Brittain K, Phillips TK, Nguyen KK, Zerbe A, Kroon M, Myer L.
    Lancet Child Adolesc Health; 2019 Apr 02; 3(4):234-244. PubMed ID: 30773459
    [Abstract] [Full Text] [Related]

  • 4. Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life.
    Jackson CL, Frank DN, Robertson CE, Ir D, Kofonow JM, Montlha MP, Mutsaerts EAML, Nunes MC, Madhi SA, Ghosh D, Weinberg A.
    mBio; 2022 Oct 26; 13(5):e0122922. PubMed ID: 36073815
    [Abstract] [Full Text] [Related]

  • 5. Dynamics of the infant gut microbiota in the first 18 months of life: the impact of maternal HIV infection and breastfeeding.
    Grant-Beurmann S, Jumare J, Ndembi N, Matthew O, Shutt A, Omoigberale A, Martin OA, Fraser CM, Charurat M.
    Microbiome; 2022 Apr 12; 10(1):61. PubMed ID: 35414043
    [Abstract] [Full Text] [Related]

  • 6. HIV-exposed uninfected infant morbidity and mortality within a nationally representative prospective cohort of mother-infant pairs in Zimbabwe.
    Patel MR, Mushavi A, Balachandra S, Shambira G, Nyakura J, Mugurungi O, Kilmarx PH, Rivadeneira E, Dinh TH.
    AIDS; 2020 Jul 15; 34(9):1339-1346. PubMed ID: 32590432
    [Abstract] [Full Text] [Related]

  • 7. Role of antenatal plasma cytomegalovirus DNA levels on pregnancy outcome and HIV-1 vertical transmission among mothers in the University of Zimbabwe birth cohort study (UZBCS).
    Duri K, Chimhuya S, Gomo E, Munjoma PT, Chandiwana P, Yindom LM, Mhandire K, Ziruma A, Mtapuri-Zinyowera S, Mazengera LR, Misselwitz B, Gumbo FZ, Jordi S, Rowland-Jones S, for (UZBCS) The U Z Birth Cohort Study Team.
    Virol J; 2021 Jan 29; 18(1):30. PubMed ID: 33514390
    [Abstract] [Full Text] [Related]

  • 8. Cohort profile: longitudinal and population comparison of children who are HIV-exposed uninfected and children who are HIV unexposed in Kenya (HOPE study).
    Njuguna IN, King'e M, Moraa H, Kumar M, Benki-Nugent S, Wagner AD, McGrath CJ, Dorsey S, Ndegwa S, Onyango A, Wamalwa D, John-Stewart G.
    BMJ Open; 2024 Jun 06; 14(6):e081975. PubMed ID: 38844397
    [Abstract] [Full Text] [Related]

  • 9. The Bern Birth Cohort (BeBiCo) to study the development of the infant intestinal microbiota in a high-resource setting in Switzerland: rationale, design, and methods.
    Cecchini L, Barmaz C, Cea MJC, Baeschlin H, Etter J, Netzer S, Bregy L, Marchukov D, Trigo NF, Meier R, Hirschi J, Wyss J, Wick A, Zingg J, Christensen S, Radan AP, Etter A, Müller M, Kaess M, Surbek D, Yilmaz B, Macpherson AJ, Sokollik C, Misselwitz B, Ganal-Vonarburg SC.
    BMC Pediatr; 2023 Nov 10; 23(1):560. PubMed ID: 37946167
    [Abstract] [Full Text] [Related]

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 11. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K, Munjoma PT, Mataramvura H, Mazhandu AJ, Chandiwana P, Marere T, Gumbo FZ, Mazengera LR.
    BMC Infect Dis; 2023 Oct 27; 23(1):736. PubMed ID: 37891471
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, Spyer M, Tumukunde D, Nathoo K, Munderi P, Kyomugisha H, Hakim J, Grosskurth H, Gilks CF, Walker AS, Musoke P, DART trial team.
    PLoS Med; 2012 Oct 27; 9(5):e1001217. PubMed ID: 22615543
    [Abstract] [Full Text] [Related]

  • 13. Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants.
    Yin L, Venturi GM, Barfield R, Fischer BM, Kim-Chang JJ, Chan C, De Paris K, Goodenow MM, Sleasman JW.
    Front Immunol; 2024 Oct 27; 15():1443886. PubMed ID: 39328414
    [Abstract] [Full Text] [Related]

  • 14. Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol.
    Shivakoti R, Slogrove AL, Laughton B, Shafiq M, Schoeman E, Glashoff RH, Leu CS, Wang S, Bode L, Aldrovandi G, Kuhn L.
    BMJ Open; 2022 Dec 30; 12(12):e069116. PubMed ID: 36585139
    [Abstract] [Full Text] [Related]

  • 15. Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.
    Desmonde S, Goetghebuer T, Thorne C, Leroy V.
    Curr Opin HIV AIDS; 2016 Sep 30; 11(5):465-476. PubMed ID: 27716731
    [Abstract] [Full Text] [Related]

  • 16. Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort.
    Sevenoaks T, Wedderburn CJ, Donald KA, Barnett W, Zar HJ, Stein DJ, Naudé PJW.
    Brain Behav Immun; 2021 Jan 30; 91():65-73. PubMed ID: 32860940
    [Abstract] [Full Text] [Related]

  • 17. Maternal breastfeeding and education impact infant growth and development more than in-utero HIV/antiretroviral therapy exposure in context of universal antiretroviral therapy.
    Cherkos AS, LaCourse SM, Kinuthia J, Mecha J, Enquobahrie DA, Escudero JN, John-Stewart G.
    AIDS; 2024 Mar 15; 38(4):537-546. PubMed ID: 37967230
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa.
    le Roux SM, Abrams EJ, Nguyen K, Myer L.
    Trop Med Int Health; 2016 Jul 15; 21(7):829-45. PubMed ID: 27125333
    [Abstract] [Full Text] [Related]

  • 19. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.
    Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, Mutasa K, Ruff A, Ward B, ZVITAMBO Study Group.
    Pediatr Infect Dis J; 2011 Jan 15; 30(1):45-51. PubMed ID: 21173675
    [Abstract] [Full Text] [Related]

  • 20. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.